Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 108 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1071 11.0 months Ovarian Cancer 4 Chemotherapy
National Kyushu Cancer Center Japan 8/2014
Treatment Details: Patients: This study involved 18 recurrent ovarian, peritoneal, or fallopian tube carcinoma patients who had been previously treated. The median patient age was 61.9 years. Treatment:
 
1072 11.0 months Metastatic Melanoma 5 Immunotherapy
Dermatologikum Berlin Germany 8/2014
Treatment Details: Patients: This phase 2 study involved 32 previously treated metastatic melanoma patients with an average age of 65.4 years; 53.1% were male. Treatment: Patients received aviscumine, an
 
1073 11.0 months NHL 4 Chemotherapy
University of Tokyo Japan 6/2015
Treatment Details: Patients: This study involved 22 peripheral T cell lymphoma patients who had received prior treatment. The median patient age was 59 years and 64% were male. Treatment: Patients receiv
 
1074 11.0 months Malignant Pleural Mesothelioma 4 Chemotherapy
Eskisehir Osmangazi University Turkey 7/2015
Treatment Details: Patients: This study involved malignant pleural mesothelioma patients who were separated into two different treatment groups. Group A consisted of 116 patients, 58 of whom were male, with a
 
1075 11.0 months Malignant Pleural Mesothelioma 4 Chemotherapy
Eskisehir Osmangazi University Turkey 7/2015
Treatment Details: Patients: This study involved malignant pleural mesothelioma patients who were separated into two different treatment groups. Group A consisted of 116 patients, 58 of whom were male, with a
 
1076 11.0 months NSCLC 5 Biologic therapy
Chemotherapy
LungenClinic Grosshansdorf Germany 3/2014
Treatment Details: Patients: This phase 2 study involved previously untreated non-small cell lung cancer patients who were divided into two separate treatment groups. Group A had 34 patients with a median ag
 
1077 11.0 months Metastatic uveal melanoma 4 Biologic therapy
Chemotherapy
University of Washington United States 11/2012
Treatment Details: Patients: This phase 2 study involved 24 metastatic uveal melanoma patients. The median patient age was 61 years and 50% were male. Treatment: Patients were treated with the chemothera
 
1078 11.0 months Extensive-disease SCLC 5 Biologic therapy
Chemotherapy
Research Institute and Hospital, National Cancer Center Korea 11/2010
Treatment Details: Patients: This phase II study involved 61 patients with extensive-disease small-cell lung cancer who had not previously received chemotherapy. The median age was 65 years and 92% were male
 
1079 11.0 months Stage IV melanoma 4 Biologic therapy
Chemotherapy
The Angeles Clinic and Research Institute United States 7/2011
Treatment Details: Patients: This phase II study involved stage IV melanoma patients who were divided into three separate treatment groups. Group A consisted of 32 patients with a median age of 64 years; 56%
 
1080 11.0 months Non-squamous NSCLC 5 Chemotherapy
San Luigi Hospital Italy 8/2012
Treatment Details: Patients: This study involved non-squamous non-small-cell lung cancer patients, not previously treated with chemotherapy, who were separated into two different treatment groups. Group A ha
 
Page 108 of 187  | Previous Page  | Next Page